An NRC IRAP investment will help four Canadian businesses to produce safe and effective treatments for those fighting the COVID-19 virus, while also building strong domestic plans to fight future pandemics.
The Government of Canada has extended the Innovation Assistance Program (IAP) by $155 million to continue supporting Canadian businesses through the adverse economic impacts caused by COVID-19.
CEWS’ strict eligibility criteria leaves many businesses ineligible to receive funding. These alternative wage subsidies can help your business through COVID-19.
The Government of Canada’s NRC-IRAP program has granted $300K to Toronto company CleanSlate UV to test and produce mobile device disinfection machines.
With help from NRC-IRAP COVID-19 funding of $299,190, portable coronavirus tests are currently being developed by Canadian biotechnology company Nicoya.
NRC-IRAP funding is helping businesses research and develop alternative methods for COVID-19 prevention. Learn how you can help and what others are doing to fight COVID-19.
NRC IRAP has launched the Innovation Assistance Program (IAP) with a total of $250 million in wage subsidies for innovative businesses ineligible for CEWS.
